Biomedical Warming and Thawing Devices Market Size By Product (Manual, Automatic), By Sample (Blood Products, Ovum/Embryo, Semen), By End-use (Hospitals, Research Laboratories, Pharmaceutical Industry, Blood Banks and Transfusion Centers), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Jul 2021  |  Report ID: GMI2912  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 140   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Biomedical Warming and Thawing Devices Market size was valued at around USD 179 million in 2020 and is estimated to grow at a CAGR of 8.5% between 2021 and 2027. Increasing use of cryopreservation techniques for preservation of cells and tissues is expected to drive the market growth. Augmenting demand for automated biomedical warming and thawing devices is also contributing positively to the market expansion. Growing demand for pharmaceutical research is further poised to increase the adoption rate for biomedical warming and thawing devices, thereby fuelling the market progression during the forecast timeframe.
 

Biomedical Warming and Thawing Devices Market Overview

Get more details on this report - Request Free Sample PDF
 

However, concerns associated with large batch size and stringent regulatory protocols related to use of cryopreserved and thawed biomedical products may render negative impact on the biomedical warming and thawing devices market share. Technical concerns such as low survival of the biomaterial sample, altered gene expression, loss of cellular characteristics, epigenetic changes, and shift in protein composition may limit the industry expansion. Moreover, regulatory guidelines for utilizing cryopreserved biologics in biomedical research have boosted the requirement for documented cell handling protocols. The storage and thawing of biomedical products are a complicated, sensitive and technology-oriented procedure.
 

Ideal conditions need to be maintained as per the guidelines for cryopreserved products to ensure maximum survival rate, viability, and functional importance. As a result, the storage and thawing of blood components and other products is monitored continuously by the U.S. FDA. The protocol differs as per country, as the mandate for defrosting and transportation of blood products differ with variable levels of technical assistance and legal framework. The regulatory frameworks majorly comprise of legislative instruments including legislation and regulations along with non-legislative instruments that includes policies, guidelines and supporting documents.
 

The COVID-19 pandemic has rendered slightly impact on the biomedical warming and thawing devices market. The SARS-CoV-2 outbreak has affected the global economy by increasing disease burden and inflicting significant economic damage in countries around the world. Various sectors have witnessed the impact of the pandemic causing financial adversities and healthcare sector was at the forefront. Additionally, prioritization of production of vital medical equipment for healthcare workers and heavy investments in research activities related to COVID-19 worldwide has led to negligence in non-COVID-19 medical field. This negligence resulted in reduced funding for R&D activities associated with the biomedical warming and thawing devices subsequently causing impact on the business.
 

Supply chain and logistics played pivotal role in transportation of cryopreserved biologics. The travel restrictions during the pandemic hampered the supply chain and restricted the movement of cryopreserved stem cells, blood products and other products further limiting the biomedical warming and thawing devices market progression. However, cryopreservation and preserved biologic products are essential for cell therapy and is predicted to continue despite the COVID-19 pandemic norms. Several stem cell transplant centers such as the National Marrow Donor Program (NMDP) suggested the stem cell products to be frozen for preservation. Owing to the pandemic’s impact on cell donor and hospital availability along with transportation restrictions, transplant centers recommended cryopreservation of stem cell products. Rise in cryopreservation of biologics is projected to stimulate the biomedical warming and thawing devices market demand.
 

Rising cases of road accidents and trauma are slated to influence the need for biomedical warming and thawing devices. According to the World Health Organization (WHO), road accidents account for approximately 1.3 million deaths annually, affecting around 20 to 50 million people with non-fatal injuries. Road accidents also inflict substantial economic impact especially in the developing nations, accounting for nearly 3% of the gross domestic product (GDP). Similarly, the Population Reference Bureau (PRB) of U.S. forecasts that the road accidents and related mortalities are set to become third leading cause of disease burden across the world. Deaths due to injuries have accounted for over 6 million on yearly basis and trauma along with haemorrhage is responsible for 30% to 40% of those deaths.
 

Thus, for managing the patients sustaining from accidental injuries and trauma, blood transfusion is a vital part of therapeutics that helps in health management in these cases. Evidence suggest that providing blood and blood components to severely bleeding trauma patients assists in curbing the patient morbidity and mortality rate. According to the PLOS Medicine’s research, blood transfusion in trauma-related cases promotes survival chances. Biomedical warming and thawing devices are extensively used in heating and defrosting cryopreserved blood and blood components. Increasing incidence of accidents across the globe are triggering the demand for blood transfusion which is anticipated to significantly promote the biomedical warming and thawing devices market revenue during the forecast period.
 

Numerous advantages offered by automatic devices are estimated to promote the market demand

The biomedical warming and thawing devices market for automatic segment is set to showcase 8.8% growth rate through 2027 led by the growing preference for automated systems and numerous advantages offered by automated thawing devices. The warming rate plays a pivotal role in cryopreserved cells, blood products and other biologics as it affects the cellular recovery and viability. Automated biomedical warming and thawing devices are designed to facilitate rapid and contamination-free thawing of the biological contents that ensures high reproducibility along with reduced risk of contamination, further incorporating standardization in this critical phase. The use of automated biomedical warming and thawing devices at commercial level for managing large batch size is further augmenting the segment growth.
 

Higher incidence of accidental injuries is driving the demand for blood products, thereby boosting thawing devices acceptance

The blood products segment had captured around 46% of the biomedical warming and thawing devices market share in 2020 impelled by the rising accidental deaths and injuries causing severe bleeding and blood loss around the world. Accidental injuries are one of the major causes of mortality and morbidity in developing as well as developed countries. Patients affected due to severe road crash injuries experience severe bleeding and require transfusion of red blood cells and blood products that are preserved using cryopreservation.
 

Growing number of blood banks and transfusion centers is slated to surge the industry value

Biomedical Warming and Thawing Devices Market Size

Get more details on this report - Request Free Sample PDF

 

The blood banks and transfusion centers segment in the biomedical warming and thawing devices market accounted for USD 57 million in 2020 driven by the national policies of several countries promoting donation of blood and plasma that has led to growing number of blood banks & transfusion centers across the globe. According to the World Health Organization (WHO), around 7.8 million increased blood donations have been reported from 2013 to 2018 from voluntary donors. Over 13,300 authorized blood centers in 169 countries collected 106 million blood donations in 2018 and the number is further expected to increase. Furthermore, the implementation of favourable initiatives for blood donation and setting-up blood banks is further propelling the segment expansion. Among the participant countries in the WHO survey, around 123 countries out of 171 had implemented a national blood policy to promote blood transfusion.
 

Increasing percentage of accidental deaths and trauma injuries in the North America region is spurring the regional growth

Global Biomedical Warming and Thawing Devices Market

Get more details on this report - Request Free Sample PDF

 

U.S. dominated the North America biomedical warming and thawing devices market in 2020 and is projected to reach over USD 92 million by 2027 on account of several factors such as growing acceptance of advanced biomedical warming and thawing devices & rise in incidence of people affected with trauma across the country. Trauma is amongst the leading mortality causes for adults aged 46 years and below in the U.S. and the mortality associated with trauma has surged by 23% in the recent years. In the elderly population that is highly susceptible to injuries, around 56% increase in trauma was reported. Blood-transfusion services are extensively utilized in treating trauma and haemorrhage patients. Increasing incidence of trauma is accelerating the demand for blood and blood products.
 

Germany biomedical warming and thawing devices market is anticipated to cross around USD 13 million by 2027. The significant market share is credited to the high number of females suffering from infertility in the country. Moreover, as per a published article in 2018, the number of female infertility cases in Germany was set around 1.6 million cases. High number of female infertility cases is expected to surge the demand for products such as embryo and semen used in infertility treatment that are preserved using cryopreservatives, thereby creating demand for biomedical warming and thawing devices.
 

Strategies adopted by major industry participants will promote the business growth

Some of the major companies operating in the biomedical warming and thawing devices market are Helmer Scientific, Brook Life Sciences, Sartorius AG, Sarstedt AG & Co. KG, Boekel Scientific, Barkey, Cytiva, Cardinal Health, and BioLife Solutions. Major industry players are implementing several strategic formulations to capitalize on company growth and drive product sales. Strategic initiatives such as forward integration, product commercialization, distribution partnerships and expansion of production capabilities among others are adopted.
 

Recent industry developments:

  • In July 2020, FreMon Scientific received the U.S. FDA approval for its ZipThaw device for plasma thawing. ZipThaw is a dry and portable plasma thawing system. This strategic move strengthened the product portfolio of the company and offered competitive advantage.
     
  • In September 2017, GE Healthcare (Cytiva) introduced the VIA Thaw CB1000 intended for thawing large batches of cryopreserved cell therapies. The range of advanced automated, dry thawers enables the users to control thawing of sensitive therapies, and addresses multiple challenges witnessed by cell therapy companies. This launch of innovative product range aided the company in driving the product sales, thereby assisting in revenue generation.
     

Biomedical warming and thawing devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product, 2016 - 2027 (USD Million)

  • Manual
  • Automatic

Market, By Sample, 2016 - 2027 (USD Million)

  • Blood Products
  • Ovum/Embryo
  • Semen
  • Others

Market, By End-use, 2016 - 2027 (USD Million)

  • Hospitals
  • Research Laboratories
  • Pharmaceutical Industry
  • Blood Banks and Transfusion Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Iran
       

Frequently Asked Questions (FAQ) :

The market size of biomedical warming and thawing devices exceeded USD 179 million in 2020 and will observe a CAGR of 8.5% through 2027.
Automatic segment will witness a CAGR of 8.8% through 2027 with growing preference for automated systems and numerous advantages offered by automated thawing devices.
Blood products segment had held around 46% market share in 2020 on account of increasing accidental deaths and injuries causing severe bleeding and blood loss globally.
Blood banks and transfusion centers segment had recorded valuation of USD 57 million in 2020 owing to the policies in various countries promoting blood and plasma donation.
U.S. market will record valuation of over USD 92 million by 2027 on account of rising cases of trauma and growing acceptance of advanced devices in the country.

Premium Report Details

  • Published Date: Jul 2021
  • Pages: 140
  • Tables: 188
  • Charts / Figures: 15
  • Companies covered: 10
  • Countries covered: 19

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X